Tag - ERYP

ERYTECH Pharma’s (NASDAQ:ERYP) eryaspase received FDA fast track designation for the second-line treatment of patients with metastatic pancreatic cancer. Eryaspase is being evaluated in a Phase 3 trial, called TRYbeCA...